Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00516256 · ClinicalTrials.gov registry record · NA
CHESS: Human and Computer Mentors for Prostate Cancer Patients
A NA study, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 209
- Enrollment target
NCT00516256: Completed NA study, sponsored by M.D. Anderson Cancer Center.
NCT00516256 is a NA study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 209 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00516256, a NA study, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 209 participants
- Enrollment target
Study Summary
The aims include: 1. To measure the effect of the three study conditions on Quality of Life (QOL). * CHESS and Cancer Information Mentor will not differ initially (6 weeks) or late in treatment (6 months) in QOL * CHESS +Cancer Information Mentor will have the largest impact on QOL (initially and late in treatment) and will be significantly better than either CHESS or Cancer Information Mentor alone. 2. To measure potential intervening or mediating processes, so that we can determine how CHESS and the Cancer Information Mentor produce associated QOL benefits. 3. To conduct exploratory use analyses examining which types of CHESS content, sequential patterns of content use, or other characteristics of use behavior are associated with greater pretest-posttest improvements in QOL. 4. To conduct a secondary analysis exploring whether men whose partners have actively used CHESS do better than those whose partners did not use CHESS.
Interventions
- BEHAVIORAL CHESS System
- BEHAVIORAL Cancer Information Mentor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 209 participants |
| Start Date | 2007-07-03 |
| Est. Completion | 2018-05-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00516256
The ClinicalTrials.gov registry entry for NCT00516256 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 209 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which CHESS System is the first listed.
NCT00516256 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00516256 about?
NCT00516256 is a clinical study titled "CHESS: Human and Computer Mentors for Prostate Cancer Patients". The aims include: 1. To measure the effect of the three study conditions on Quality of Life (QOL). * CHESS and Cancer Information Mentor will not differ initially (6 weeks) or late in treatment (6 months) in QOL * CHESS +Cancer Information Mentor will have the largest impact on QOL (initiall...
What is the current status of trial NCT00516256?
This trial is currently completed. It is a NA study. The enrollment target is 209 participants. The study started on 2007-07-03. Estimated completion is 2018-05-11.
What interventions are being tested in trial NCT00516256?
The interventions under investigation include: CHESS System (BEHAVIORAL), Cancer Information Mentor (BEHAVIORAL).
Who is sponsoring clinical trial NCT00516256?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.